Journal article
Clinical Characteristics and Outcomes of Patients With Coronary Artery Disease and Angina
Abstract
BACKGROUND: The aim of our study was to investigate the relationship between coronary artery disease (CAD), angina, and clinical outcomes in patients with heart failure and preserved ejection fraction enrolled in the irbesartan in patients with heart failure and preserved systolic function (I-Preserve) trial.
METHODS AND RESULTS: The mean follow-up period for the 4128 patients enrolled in I-Preserve was 49.5 months. Patients were divided into 4 …
Authors
Badar AA; Perez-Moreno AC; Hawkins NM; Jhund PS; Brunton APT; Anand IS; McKelvie RS; Komajda M; Zile MR; Carson PE
Journal
Circulation Heart Failure, Vol. 8, No. 4, pp. 717–724
Publisher
Wolters Kluwer
Publication Date
7 2015
DOI
10.1161/circheartfailure.114.002024
ISSN
1941-3289
Fields of Research (FoR)
Sustainable Development Goals (SDG)
Medical Subject Headings (MeSH)
AgedAngina PectorisAngiotensin II Type 1 Receptor BlockersBiphenyl CompoundsCoronary Artery DiseaseDeath, Sudden, CardiacFemaleHeart FailureHumansIrbesartanKaplan-Meier EstimateMaleMiddle AgedProportional Hazards ModelsRandomized Controlled Trials as TopicRetrospective StudiesRisk AssessmentRisk FactorsStroke VolumeSystoleTetrazolesTime FactorsTreatment OutcomeVentricular Function, Left